Cambridge Investment Research Advisors’s FT Vest US Equity Moderate Buffer ETF November GNOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-25,386
Closed -$988K 3934
2026
Q1
$988K Sell
25,386
-1,789
-7% -$71K ﹤0.01% 2178
2025
Q4
$1.08M Buy
27,175
+7,284
+37% +$283K ﹤0.01% 2035
2025
Q3
$757K Sell
19,891
-11,665
-37% -$434K ﹤0.01% 2289
2025
Q2
$1.15M Sell
31,556
-3,261
-9% -$113K ﹤0.01% 1843
2025
Q1
$1.19M Sell
34,817
-58,364
-63% -$2.05M ﹤0.01% 1718
2024
Q4
$3.26M Buy
93,181
+84,599
+986% +$2.95M 0.01% 1044
2024
Q3
$296K Buy
8,582
+718
+9% +$24.4K ﹤0.01% 2841
2024
Q2
$266K Hold
7,864
﹤0.01% 2802
2024
Q1
$259K Hold
7,864
﹤0.01% 2822
2023
Q4
$249K Buy
+7,864
New +$245K ﹤0.01% 2740

Other funds holding GNOV

Cambridge Investment Research Advisors's GNOV Position: Q2 2026 in Review

Cambridge Investment Research Advisors sold out of FT Vest US Equity Moderate Buffer ETF November (GNOV) in Q2 2026, closing a stake of 25,386 shares — an estimated $988K sold.

Cambridge Investment Research Advisors first reported a position in GNOV in Q4 2023 and held it in 10 quarters. The position peaked at $3.26M in Q4 2024. 33 funds tracked by Wall St. Rank hold GNOV as of Q2 2026.

  • Cambridge Investment Research Advisors reported no remaining FT Vest US Equity Moderate Buffer ETF November position as of Q2 2026 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 25,386 FT Vest US Equity Moderate Buffer ETF November shares in Q2 2026, an estimated $988K.
  • Cambridge Investment Research Advisors first reported a position in FT Vest US Equity Moderate Buffer ETF November in Q4 2023 and held it in 10 quarters.
  • Cambridge Investment Research Advisors's FT Vest US Equity Moderate Buffer ETF November position peaked at $3.26M in Q4 2024.
  • 33 funds tracked by Wall St. Rank held FT Vest US Equity Moderate Buffer ETF November as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.